Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs Superior Remedies

CoreAge Rx
Graded #1

Higher grade

vs+34.3
Superior Remedies
Graded #404

Lower grade

The verdict

CoreAge Rx takes it — 91.8/100 to 57.5/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

CoreAge Rx is also our overall #1 pick — it tops the full scorecard at 91.8/100 (A−).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +67
92
25
Dose & formulationCoreAge Rx +33
88
55
Clinical oversightCoreAge Rx +13
93
80
Labs & monitoringCoreAge Rx +30
90
60
FulfillmentCoreAge Rx +23
95
72
Contract termsCoreAge Rx +14
96
82
CoreAge Rx · left barSuperior Remedies · right bar

The numbers

MetricCoreAge RxSuperior Remedies
WeighScore91.8/10057.5/100
GradeA−C
Scorecard rank#1#404
Semaglutide$149/moNot disclosed
Tirzepatide$349/moNot disclosed
CoverageAll 50 statesAll 50 states (telehealth nationwide)
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
CoreAge Rx

Graded #1 · A−

Strengths

  • Flat all-in price with no month-two step-up
  • Semaglutide and tirzepatide on one account
  • All 50 states, LegitScript-verified

Where it loses points

  • Not the cheapest sticker price
  • Compounded only
  • Pharmacy partner not yet publicly named
Superior Remedies

Graded #404 · C

Strengths

  • Runs a dedicated GLP-1 Microdose program with its own page, framed for metabolic health and body composition rather than aggressive weight loss
  • Publishes a clinical exclusion that turns business away: patients with significant weight to lose are told they would be better served by a standard GLP-1 protocol
  • Charges nothing if you are not approved, and states telehealth availability in all 50 states
  • Names its exclusions plainly, including medullary thyroid carcinoma or MEN 2 history and pregnancy

Where it loses points

  • ⚠⚠ No price on any program page — the only public figure is a homepage headline labeled a limited-time offer and attached to the general pitch rather than to a program
  • ⚠ No milligram figure anywhere, so "microdose" describes an intent rather than an amount
  • No compounding pharmacy is named
  • Compounded GLP-1s are not FDA-approved

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard